Tower Research Capital LLC (TRC) - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2022$0
-100.0%
660
-93.8%
0.00%
Q3 2022$13,000
-62.9%
10,689
-43.5%
0.00%
-100.0%
Q2 2022$35,000
-85.2%
18,928
-83.8%
0.00%
-50.0%
Q1 2022$236,000
+73.5%
116,671
+132.2%
0.00%0.0%
Q4 2021$136,000
-48.1%
50,252
-14.2%
0.00%
-71.4%
Q3 2021$262,000
+184.8%
58,579
+267.8%
0.01%
+250.0%
Q2 2021$92,000
+155.6%
15,926
+213.1%
0.00%
+100.0%
Q1 2021$36,000
-21.7%
5,086
-46.6%
0.00%0.0%
Q4 2020$46,000
-92.7%
9,522
-91.2%
0.00%
-85.7%
Q3 2020$634,000
+93.3%
108,741
+123.8%
0.01%
-46.2%
Q2 2020$328,000
+16300.0%
48,589
+21786.9%
0.01%
Q4 2019$2,0000.0%222
-57.4%
0.00%
Q3 2019$2,0000.0%521
+280.3%
0.00%
Q2 2019$2,000
-86.7%
137
-77.8%
0.00%
-100.0%
Q1 2019$15,000
+650.0%
617
+517.0%
0.00%
Q4 2018$2,000
-33.3%
100
+108.3%
0.00%
Q1 2018$3,000
-93.0%
48
-92.4%
0.00%
-100.0%
Q4 2017$43,000
-82.7%
631
-79.0%
0.01%
-70.0%
Q3 2017$248,000
+4033.3%
3,003
+3129.0%
0.02%
+1900.0%
Q1 2017$6,000
-97.0%
93
-97.9%
0.00%
-95.5%
Q4 2016$200,000
+104.1%
4,493
-36.8%
0.02%
+144.4%
Q2 2016$98,000
+292.0%
7,105
+449.9%
0.01%
+125.0%
Q1 2016$25,000
-58.3%
1,292
-24.4%
0.00%
-60.0%
Q4 2015$60,000
+87.5%
1,709
+364.4%
0.01%
+233.3%
Q2 2015$32,000
-61.0%
368
-66.8%
0.00%
-70.0%
Q1 2015$82,000
+4000.0%
1,108
+2894.6%
0.01%
Q4 2014$2,000
-50.0%
37
-61.5%
0.00%
Q3 2014$4,000
-63.6%
96
-65.2%
0.00%
-100.0%
Q2 2014$11,000
-87.8%
276
-78.9%
0.00%
-91.7%
Q1 2014$90,000
+125.0%
1,306
+99.1%
0.01%
+71.4%
Q4 2013$40,000
-44.4%
656
-44.6%
0.01%
-12.5%
Q3 2013$72,000
-6.5%
1,185
+3.0%
0.01%
+33.3%
Q2 2013$77,0001,1500.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders